Screening mammography beginning at age 40 years

Rosenquist, C. J.; Lindfors, Karen K.

doi:10.1002/(sici)1097-0142(19980601)82:11<2235::aid-cncr19>3.0.co;2-v

Cited by 72 publications

(34 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As illustrated in Table 4, when the countries are Woo et al, 2007;3 : Carles et al, 2011;4 : Garuz et al, 1997;5 : Van der Maas et al, 1989;6 divided into two groups, one including India (Okonkwo et al, 2008), Japan (Okubo et al, 1991), China (Woo et al, 2007;Wong et al, 2010), and Korea (Kang et al, 2013), and the other including the UK (Knox, 1988), (Leivo et al, 1999), The Netherlands (Leivo et al, et al, 2009), and the US (Lindfors and Rosenquist, 1995;Rosenquist and Lindfors, 1998;Stout et al, 2006;Wong et al, 2010;Schousboe et al, 2011) on the basis of the cut-off point of 45.04 for the incidence rates, there was Asian and Western countries. This illustrates that there is difference in the cost-effectiveness of breast cancer mammography screening between Asian countries such as India, Japan, China, and Korea with low incidence rates, and Western countries such as the UK, Spain, Finland, with relatively higher incidence rates.…”

Section: Discussionmentioning

confidence: 99%

“…The reference year of cost indicates the year of cost data in each study. Among 16 studies, 11 studies (de Koning et al, 1991;and Lindfors, 1998;Stout et al, 2006;Woo et al, 2007;Okonkwo et al, 2008;de Gelder et al, 2009;Wong et al, 2010;Carles et al, 2011;Schousboe et al, 2011) of scenarios. The other 5 studies (Knox, 1988;Okubo et al, 1991;Leivo et al, 1999;Norum, 1999;Kang et al, the cost-effectiveness of a single screening strategy, with the mammography screening strategy that was being implemented in the corresponding country at that time.…”

Section: Mammography Cost-effectiveness Literature Reviewmentioning

confidence: 99%

“…Rosenquist et al (1998) sought to re-appraise the costeffectiveness of mammography screening in the 40-49 years of age group.…”

Section: Mammography Cost-effectiveness Literature Reviewmentioning

confidence: 99%

See 2 more Smart Citations

Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review

Yoo

Kwon

Cho

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries. Materials and Methods: A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal costeffectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by rate boundary line determining whether mammography screening is cost-effective or not. Results: We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p<0.0014). Conclusions: Mammography screening is cost-effective in most of Western countries, but not in Asian countries. The reason for this result may be the issues of incidence rate or racial characteristics, such as dense breast tissue. The results indicate that mammography screening should be adopted prudently in Asian countries and other countries with low incidence rates.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Mammography Cost-effectiveness Literature Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review

Yoo

Kwon

Cho

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…A maioria dos trabalhos internacionais também utilizou apenas esses cenários 7,29,30 . Em um dos poucos estudos na literatura que comparou a realidade atual em termos de rastreamento de câncer de mama com outras opções, nos Estados Unidos, foi visto que os custos para rastrear mulheres entre 50 e 75 anos de idades a cada dois anos eram menores que os gastos incorridos com rastreamento naquele momento no país, apresentando uma efetividade maior, desta forma dominando o cenário corrente de rastreamento 6 .…”

Section: Discussionunclassified

Custo-efetividade de um programa de rastreamento organizado de câncer de mama no Sul do Brasil

2013

View full text Add to dashboard Cite

O objetivo deste estudo foi avaliar o custo-efetividade de um programa organizado de rastreamento mamográfico de câncer de mama implementado na cidade de Porto Alegre, Rio Grande do Sul, Brasil (Núcleo Mama Porto Alegre - NMPOA). Foi construído modelo de Markov para estimar a relação de custo-efetividade incremental do NMPOA em comparação à situação atual de atenção ao câncer de mama no SUS, em coorte hipotética de mulheres de 40-69 anos com risco de desenvolver câncer de mama. Os parâmetros foram coletados do NMPOA e da literatura nacional. Na estratégia NMPOA, a efetividade foi modelada levando-se em conta a real adesão da população participante do rastreamento. A efetividade foi medida em anos de vida ajustados para qualidade (QALY). A relação de custoefetividade incremental no caso base foi de R$ 13.426,00 por QALY. Esse resultado foi pouco sensível à variação dos principais parâmetros do modelo nas análises de sensibilidade. Considerando o limiar usualmente sugerido como bastante atrativo do ponto de vista econômico no Brasil, o rastreamento do câncer de mama nos moldes do NMPOA é custo-efetivo em cidades com alta incidência deste tipo de câncer.

show abstract

“…60 In the context of breast screening, Markov models have been used to estimate the cost-effectiveness of digital mammography and the cost-effectiveness of extending screening to women aged 40-49 years. 61 Extrapolation from intermediate outcome measures, such as cancers detected, to final outcome measures, such as life-years gained, was used in the trial of one-and two-view mammography, 49 although the methods used were quite crude as the estimation of future costs and benefits was based on an assumption that the same percentage rate of increase in cancers detected achieved with two views would apply to the rate of mortality reduction.…”

Section: Overview Of Modelling Approachmentioning

confidence: 99%

Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography

Taylor

Champness²,

Given-Wilson³

et al. 2005

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAImpact of computer-aided detection prompts on the sensitivity and specificity of screening mammography This report should be referenced as follows:Taylor P, Champness J, Given-Wilson R, Johnston K, Potts H. Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography. Health Technol Assess 2005;9(6). Health Technology Assessment is indexed and abstracted in NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Sugge...

show abstract

Screening mammography beginning at age 40 years

Abstract: Cost-effectiveness of four age-related mammographic screening strategies was evaluated. The MCYLS for all strategies was within a generally accepted range. With increasing concerns regarding the cost of health care, this information may be useful in health policy decision-making.

Cited by 72 publications

References 23 publications

Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review

Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review

Custo-efetividade de um programa de rastreamento organizado de câncer de mama no Sul do Brasil

Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography

Contact Info

Product

Resources

About